Skip to content
CH Master Reference

References (Part V)

  1. JAMA 2009; PMID 19996400
  2. 10.1001/jama.2009.1855
  3. Guo et al., Med Gas Res 2019, PMC7802413
  4. JHS CQ1
  5. PMC8720466
  6. 10.1002/14651858.CD005219.pub3
  7. PMC6755552
  8. 10.1186/s10194-018-0917-4
  9. EAN 2023
  10. Cephalalgia PDF
  11. 10.1111/pme.12055
  12. 10.1177/0333102415616878
  13. King’s College London research portal
  14. Ray, Stark, Hutton, Aust Prescr 2022;45:15–20
  15. 10.18773/austprescr.2022.004
  16. OUCH-UK, Oxygen for CH 2023
  17. PMC9163947
  18. 10.3988/jcn.2022.18.3.271
  19. DMKG “Sauerstoffbehandlung bei Cluster-Kopfschmerz”
  20. Exeter Headache Clinic 2021/2023
  21. OUCH Belgium oxygen leaflet
  22. OUCH-UK forum, oxygen use
  23. Clusterbusters CMS coverage page
  24. Clusterbusters oxygen knowledgebase
  25. clusterinfo.org oxygen guide
  26. Clusterbusters provider guide
  27. r/clusterheads thread
  28. PMID 30221765
  29. 10.1111/head.13405
  30. PMID 30632614
  31. PMC9436841
  32. 10.1007/s11916-022-01063-5
  33. OUCH-UK GP/neurologist information
  34. NHS England London
  35. CMS decision memo
  36. CMS public comments
  37. Alliance for Patient Access
  38. US Pain Foundation, “The Never-Ending Battle for Oxygen Coverage”
  39. DMKG 2016 cluster guideline
  40. DGN guideline
  41. MHLW documentation
  42. Japanese Neurology Society 2021 headache guideline
  43. Sundhed.dk patient handbook, klyngehovedpine
  44. Ugeskrift for Læger review
  45. DHOS Referenceprogram 2010
  46. PMID 1647496
  47. 10.1056/NEJM199108013250505
  48. PMC4170909
  49. 10.1002/14651858.CD008042.pub2
  50. Leone & Proietti Cecchini 2016, PMC4731683
  51. PMID 12601104
  52. 10.1212/01.WNL.0000046589.45855.30
  53. PMID 16966497
  54. 10.1001/archneur.63.11.nct60002
  55. PMID 17724283
  56. 10.1212/01.wnl.0000267886.85210.37
  57. NHS, sumatriptan dosing
  58. WHO EML application
  59. Aust Prescr 2022
  60. 10.1212/WNL.0000000000002117
  61. PMID 11062845
  62. PMC7018790
  63. 10.1007/s40263-019-00696-2
  64. PMID 7737866
  65. 10.1111/j.1526-4610.1995.hed3502083.x
  66. reviewed at BestBETs
  67. PMID 30098024
  68. PMC3359256
  69. DHE narrative review, PMC7003832
  70. PMID 3520384
  71. 10.1212/wnl.36.7.995
  72. Nagy et al., Neurology
  73. PMC7200221
  74. PMID 15455406
  75. 10.1002/ana.20210
  76. PMID 33245858
  77. [10.1016/S1474-4422(20)30363-X](https://doi.org/10.1016/S1474-4422(20)
  78. Leroux & Ducros, Curr Pain Headache Rep 2013;17:325
  79. Ambrosini et al., Pain 2005
  80. 10.1016/j.pain.2005.07.015
  81. PMID 21903477
  82. [10.1016/S1474-4422(11)70186-7](https://doi.org/10.1016/S1474-4422(11)
  83. PMID 21903478
  84. 10.1177/0333102416654886
  85. PMC3620288
  86. 10.1186/1129-2377-14-S1-P60
  87. PMC8940833
  88. 10.1007/s00415-021-10884-0
  89. Drug Treatment of Cluster Headache, PMC8748342
  90. Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ. Headache 2016;56(7):1093–1106, DOI 10.1111/head.12866, PMID 27432623
  91. Schmerzklinik Kiel, German-language
  92. WHO 25th EML Expert Committee review
  93. 10.1212/WNL.54.6.1382
  94. 10.1111/j.1526-4610.1990.hed3007411.x
  95. Spanish-hosted review of lithium literature, SciELO
  96. European Academy of Neurology guidelines on cluster headache, 2023, DOI 10.1111/ene.15956
  97. BASH verapamil regime
  98. Koppen H, et al. Cephalalgia 2016, DOI 10.1177/0333102416631968
  99. PMC3072493
  100. thread
  101. thread
  102. thread
  103. Neurologie pro praxi 2025;26(1):54–60
  104. PMC10476341
  105. 9350389
  106. e.g. Peres & Rozen case 1’s history of failed lithium 900 mg
  107. 10.1046/j.1468-2982.2003.00665.x
  108. 10.1097/WNF.0000000000000678
  109. 41805259
  110. Nilsson Remahl AIM, Laudon Meyer E, Cordonnier C, Goadsby PJ. Placebo Response in Cluster Headache Trials: A Review, Cephalalgia 2003
  111. 10.1212/WNL.0000000000207240
  112. PMC10259280
  113. Gooriah R, Buture A, Ahmed F. Ther Clin Risk Manag 2015;11:1687–1696, DOI 10.2147/TCRM.S94193, PMC4646474
  114. 8933994
  115. 10.1046/j.1468-2982.1996.1607494.x
  116. 10.1046/j.1526-4610.2002.02181.x
  117. 12390642
  118. 21395575
  119. 12056936
  120. 10.1046/j.1468-2982.1993.1302114.x
  121. 8495452
  122. 12047460
  123. 20055254
  124. r/clusterheads NHS thread
  125. 10.1007/s11916-001-0014-1
  126. 11252142
  127. 10.1046/j.1468-2982.1995.1505430.x
  128. 8536305
  129. systematic review and meta-analysis, Headache Medicine
  130. PMC4853809
  131. 10.1056/NEJMoa1813440
  132. 10.1177/0333102420905321
  133. 32050782
  134. 32266593
  135. PMC7419360
  136. 10.1001/jamaneurol.2025.1317
  137. Lundbeck newsroom, 2024
  138. [10.1016/S1474-4422(25)00065-1](https://doi.org/10.1016/S1474-4422(25)
  139. 40252664
  140. Thieme
  141. 10.1007/s10072-026-09078-1
  142. 42118310
  143. 10.1177/03331024261434209
  144. 41961550
  145. 10.1177/03331024231226181
  146. 38501892
  147. Emgality for chronic CH thread
  148. How long for Emgality to kick in
  149. PBS galcanezumab listing
  150. Australian Government Department of Health announcement on expanded Emgality PBS listing
  151. Migraine Australia
  152. Headache Australia
  153. Mitsikostas DD, Edvinsson L, Jensen RH, Katsarava Z, Lampl C, Negro A, Osipova V, Paemeleire K, Siva A, Valade D, Martelletti P. J Headache Pain 2014;15(1):79. DOI 10.1186/1129-2377-15-79, PMID 25430992
  154. Neurostimulation Treatment in Chronic Cluster Headache — a Narrative Review, Neurol Ther / PMC8665918, 2021
  155. Medistar Australia — gammaCore for Patients
  156. PMID 27593728
  157. Goadsby 2018, DOI 10.1177/0333102417744362
  158. PMID 31246132 / PMC6637721
  159. PMID 28197844 / PMC5309191
  160. PMID 37515405
  161. NICE MTG46, evidence chapter
  162. NICE HTG533 committee discussion
  163. PMID 34322861 / PMC8611122
  164. Ont Health Technol Assess Ser 2025;25(2):1-177, PMID 40496978 / PMC12148001
  165. NeurologyLive
  166. TGA advertising permissions — Medistar 2 Pty Ltd, gammaCore
  167. Migraine Australia — Devices
  168. Medistar — How to prescribe gammaCore in AU
  169. electroCore investor release
  170. ClusterBusters forum thread
  171. r/ClusterHeadaches — vagus nerve stimulation
  172. PMID 32109020
  173. gammaCore reviews
  174. Trigeminal Autonomic Cephalalgias: Beyond the Conventional Treatments, Curr Pain Headache Rep 2014;18(8):438 / PMC4119587
  175. PMID 23314784 / PMC3724276
  176. PMID 31701891
  177. PMID 29349561 / PMC5773459
  178. SAGE
  179. PMC4961666
  180. NHS England clinical commissioning policy document
  181. UK Companies House, company 07239097
  182. Nature — Abandoned
  183. Neurotech Reports
  184. BusinessWire, 18 August 2021
  185. Realeve / Unity HA Breakthrough Device announcement
  186. BusinessWire, 20 September 2023
  187. Promex Industries, 8 May 2025
  188. Realeve, January 2025
  189. PMID 34146510
  190. L-ICON, eBioMedicine 2023, DOI 10.1016/j.ebiom.2023.104895, PMC10755111
  191. PMID 41803706 / PMC12980930
  192. Falowski 2010
  193. PMID 39607056
  194. r/migraine — Experience with occipital nerve stimulation?
  195. cited in Leone & Proietti Cecchini, Cephalalgia 2016, DOI 10.1177/0333102415607176
  196. Karger systematic review
  197. PMID 15689358
  198. cited in Leone, IHS
  199. PMID 11398301
  200. cited in JNNP gamma knife trial
  201. PMID 12707445
  202. PMID 35112222
  203. Sydney Headache Centre
  204. PBS medicine search
  205. SA Health — Home Oxygen Therapy
  206. SA Health — Home Oxygen Adult Clinical Prioritisation Criteria
  207. SA Health Home Oxygen Therapy Booklet, PDF
  208. BOC Australia — Oxygen therapy
  209. SA Health — Home Oxygen Therapy Rebate
  210. Queensland Health MASS
  211. SWEP Domiciliary Oxygen Prescriber Manual, PDF
  212. EnableNSW respiratory
  213. DVA DMOT
  214. MASS oxygen packages and suppliers
  215. PBS item 8144P
  216. PBS item 1849H
  217. TGA ARTG 209316
  218. healthdirect — Clustran
  219. Migraine Australia — Imigran discontinuations
  220. Migraine Australia — Triptans
  221. Pharmacy Online — Clustran
  222. Chemist Warehouse — Clustran
  223. PBS item 8266C
  224. PBS verapamil items
  225. TGA AusPAR PI, PDF
  226. PBS item 12469G
  227. PBS medicine status
  228. Migraine & Headache Australia — Cluster Headache
  229. Brain Foundation
  230. Cluster Headaches Australia
  231. myclusters.nl — Patient support groups around the world
  232. change.org petition
  233. link
  234. Facebook group post
  235. thread
  236. r/clusterheads oxygen thread
  237. oxygen therapy thread
  238. CMS proposed decision memo CAG-00296R2
  239. Noridian DME MAC — Oxygen LCD L33797 update
  240. CMS LCD L33797
  241. CMS NCD “Home Use of Oxygen”
  242. FDA Imitrex injection label, PDF
  243. Drugs.com price guide — sumatriptan
  244. FDA Emgality label, PDF
  245. SingleCare
  246. MedFinder
  247. Emgality Savings Card
  248. AJMC review of nVNS/gammaCore
  249. NHS England — Good HOOF guide
  250. NHS England — HOOF letters and guidance
  251. Nottinghamshire APC pathway, PDF
  252. London cluster headache guidance for GPs and neurologists (Sept 2021)
  253. UK SmPC — sumatriptan injection
  254. NHS — prescription charges
  255. NICE HTG533, PDF
  256. DMKG — Empfehlungen Sauerstoff
  257. ck-wissen — Sauerstoff im Hilfsmittelverzeichnis
  258. AWMF S1 guideline, Clusterkopfschmerz und trigeminoautonome Kopfschmerzen, PDF
  259. dmkg.de
  260. EMA Q&A on refusal, PDF
  261. European Commission community register
  262. Emgality EPAR
  263. Schmerzklinik Kiel
  264. OxyCare — Verordnung Cluster-Kopfschmerz, PDF
  265. Clusterbusters — Oxygen therapy for cluster headaches
  266. Clusterbusters — oxygen resource
  267. patient resources hub

This is not medical advice. It is an independent, privately maintained research summary that is revised continuously and may contain errors, omissions or findings since superseded. Treatment decisions belong with a qualified clinician who knows your history.Read the full notice.

If you are in crisis, please stop reading and reach someone now — thecrisis lines are listed here.